BBA
TMO icon

Braun-Bostich & Associates’s Thermo Fisher Scientific TMO Stock Holding History

Braun-Bostich & Associates’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-424
Closed -$246K – 143
2024
Q1 		$246K Sell
424
-222
-34% -$125K 0.21% 108
2023
Q4 		$343K Sell
646
-21
-3% -$10.2K 0.31% 80
2023
Q3 		$338K Buy
+667
New +$355K 0.63% 28
2022
Q1 		– Sell
-846
Closed -$502K – 143
2021
Q4 		$502K Buy
+846
New +$528K 0.12% 62
2020
Q4 		– Sell
-789
Closed -$348K – 202
2020
Q3 		$348K Buy
789
+771
+4,283% +$319K 0.35% 41
2020
Q2 		$7K Buy
+18
New +$6.03K 0.01% 246

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Braun-Bostich & Associates's TMO Position: Q2 2024 in Review

Braun-Bostich & Associates sold out of Thermo Fisher Scientific (TMO) in Q2 2024, closing a stake of 424 shares — an estimated $246K sold.

Braun-Bostich & Associates first reported a position in TMO in Q2 2020 and held it in 6 quarters. The position peaked at $502K in Q4 2021. 2,542 funds tracked by Wall St. Rank hold TMO as of Q2 2024.

  • Braun-Bostich & Associates reported no remaining Thermo Fisher Scientific position as of Q2 2024 after selling out during the quarter.
  • Braun-Bostich & Associates sold 424 Thermo Fisher Scientific shares in Q2 2024, an estimated $246K.
  • Braun-Bostich & Associates first reported a position in Thermo Fisher Scientific in Q2 2020 and held it in 6 quarters.
  • Braun-Bostich & Associates's Thermo Fisher Scientific position peaked at $502K in Q4 2021.
  • 2,542 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2024.

Based on Braun-Bostich & Associates's 13F filing for Q2 2024, filed 13 Aug 2024.